# Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs

> **NCT00675207** · PHASE4 · COMPLETED · sponsor: **Northwestern Ophthalmic Institute S.C.** · enrollment: 120 (actual)

## Conditions studied

- Primary Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Brimonidine purite 0.15%
- **DRUG:** Dorzolamide 2%
- **DRUG:** Brinzolamide 1%

## Key facts

- **NCT ID:** NCT00675207
- **Lead sponsor:** Northwestern Ophthalmic Institute S.C.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2008-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675207, "Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00675207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*